NewDays Raises $7 Million to Democratize Cognitive Health with AI-Powered Therapy
Seattle, WA – September 3, 2025 – NewDays, a pioneering AI-driven cognitive health company, has secured $7 million in seed funding led by General Catalyst and Madrona. this investment signals a growing recognition of the urgent need for accessible and proactive solutions to address the rising prevalence of cognitive decline. The funding will fuel NewDays’ expansion, technological advancements, and ultimately, it’s mission to empower individuals facing dementia and mild cognitive impairment (MCI).
The Growing Crisis of Cognitive Decline
Cognitive impairment is a important public health concern. Currently, an estimated one in three adults over the age of 65 experiences a serious cognitive issue, impacting not only their quality of life but also placing a substantial burden on healthcare systems and families. Traditional cognitive care is often expensive, geographically limited, and constrained by a shortage of qualified professionals. NewDays aims to dismantle these barriers.NewDays: Bridging the Gap with AI and Clinical Expertise
Founded on the principles of evidence-based care and technological innovation, NewDays offers a unique hybrid approach to cognitive health. The company provides:
Telehealth Appointments: Virtual consultations with licensed cognitive clinicians deliver personalized assessment and therapy. These sessions are covered by insurance, making care more financially accessible.
AI-Powered Companion: Sunny: Beyond scheduled appointments, patients benefit from ongoing support through Sunny, an AI companion designed to deliver personalized brain exercise “homework.” This continuous engagement is crucial for reinforcing therapeutic gains and promoting long-term cognitive health. Sunny’s guidance is available for a monthly subscription of $99.
A Proactive, Holistic Approach: NewDays doesn’t simply address cognitive decline reactively. It focuses on proactive interventions designed to slow progression and improve overall well-being.The Science behind the Innovation
NewDays’ AI isn’t built on speculation; it’s grounded in rigorous clinical research. The platform is trained on data from studies like the groundbreaking Internet-Based Conversational Engagement Clinical Trial conducted by Harvard university.This research demonstrated that regular, structured conversations with a trained clinician can significantly delay cognitive decline and combat the isolation frequently enough experienced by older adults.
“For too long, people experiencing cognitive changes have been told there’s nothing they can do beyond maintaining a healthy lifestyle and preparing for decline,” explains Babak Parviz, NewDays co-founder and CEO. “But the latest research shows there are non-pharmacological interventions that can meaningfully help, and advancements in AI let us take those game-changing findings and provide them widely in a way that wasn’t technologically possible even a couple of years ago.”
Why Investors are Backing NewDays
Both General Catalyst and Madrona recognize the transformative potential of NewDays.
“NewDays exemplifies our focus on supporting healthcare solutions that make care more affordable, accessible, and proactive,” says Holly Maloney, Managing Director of General Catalyst. “Their combination of AI innovation with human clinical oversight represents the future of digital health.”
Tim Porter and Rolanda fu, of Madrona, echo this sentiment, highlighting the company’s ability to scale effective interventions.”It’s therapy that feels like companionship. Care that happens between appointments. And more than anything,it’s a way to deliver proven cognitive therapies at scale,” they wrote in a recent blog post. “What matters is that it happens without losing the human and clinical touch. For years, these interventions have been limited by one thing: they’re time-intensive and rely on a small number of highly trained professionals. NewDays solves that bottleneck.”
Expansion and Future Outlook
NewDays is currently available in California, Washington, and Florida, with plans to expand into Texas and other states. The seed funding will be strategically allocated to:
Team Growth: expanding the team of clinicians, engineers, and support staff.
Technological Advancement: further refining the AI platform and developing new features to enhance the user experience and therapeutic efficacy.
Geographic Expansion: Bringing newdays’ services to a wider population.
NewDays in the Competitive Landscape
While NewDays is a relative newcomer, it joins a growing field of companies dedicated to improving cognitive care. Key players include:
Isaac Health: Offers a extensive virtual care platform for seniors,including cognitive health support.
Synapticure:
